FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

6 results

botox
(onabotulinumtoxinA)
Allergan, Inc.
Usage: BOTOX is indicated for treating overactive bladder, detrusor overactivity in adults and pediatric patients, chronic migraines, spasticity, cervical dystonia, severe primary axillary hyperhidrosis, and blepharospasm/strabismus. It is prescribed for patients unresponsive to or intolerant of anticholinergic medications. Limitations in efficacy for specific conditions are noted.
myrbetriq
(mirabegron)
Astellas Pharma US, Inc.
Usage: MYRBETRIQ is indicated for treating adult overactive bladder (OAB) symptoms, including urge urinary incontinence, urgency, and urinary frequency, either alone or with solifenacin succinate. It is also indicated for pediatric patients (ages 3+) with neurogenic detrusor overactivity (NDO) who weigh 35 kg or more.
oxybutynin chloride
(OXYBUTYNIN CHLORIDE)
Chartwell RX, LLC
Usage: Oxybutynin chloride extended-release tablets are indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. They are also approved for pediatric patients aged 6 and older with detrusor overactivity linked to neurological conditions, such as spina bifida.
oxybutynin chloride
(Oxybutynin Chloride)
Ajanta Pharma USA Inc.
Usage: Oxybutynin chloride is indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. It is also approved for pediatric patients aged 6 and older with detrusor overactivity related to neurological conditions, such as spina bifida.
oxybutynin chloride
(Oxybutynin Chloride)
Advagen Pharma Limited
Usage: Oxybutynin chloride is indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. It is also approved for pediatric patients aged 6 and older with detrusor overactivity associated with neurological conditions such as spina bifida.
oxybutynin chloride
(oxybutynin chloride)
Accord Healthcare, Inc.
Usage: Oxybutynin chloride extended-release tablets are indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. They are also indicated for pediatric patients aged 6 and older with detrusor overactivity related to neurological conditions.

Medications for Neurogenic Detrusor Overactivity

botox

myrbetriq

oxybutynin chloride

oxybutynin chloride

oxybutynin chloride

oxybutynin chloride